BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15060810)

  • 1. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.
    Parnetti L; Caso V; Santucci A; Corea F; Lanari A; Floridi A; Conte C; Bottiglieri T
    Neurol Sci; 2004 Apr; 25(1):13-7. PubMed ID: 15060810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine and ischemic stroke patients in Thailand.
    Tantirittisak T; Sura T; Moleerergpoom W; Hanchaipiboolkul S
    J Med Assoc Thai; 2007 Jun; 90(6):1183-7. PubMed ID: 17624215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of homocysteine in the acute phase of stroke].
    Ribo M; Montaner J; Monasterio J; Molina C; Arenillas J; Chacon P; Alvarez-Sabin J
    Neurologia; 2004; 19(1):10-4. PubMed ID: 14762728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study.
    Benninger DH; Herrmann FR; Georgiadis D; Kretschmer R; Sarikaya H; Schiller A; Baumgartner RW
    Cerebrovasc Dis; 2009; 27(3):241-6. PubMed ID: 19176957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
    Kalita J; Kumar G; Bansal V; Misra UK
    Clin Neurol Neurosurg; 2009 May; 111(4):364-7. PubMed ID: 19185985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence of interrelation between homocysteine and hypertension in stroke patients: a cross-sectional study.
    Mizrahi EH; Noy S; Sela BA; Fleissig Y; Arad M; Adunsky A
    Isr Med Assoc J; 2003 Nov; 5(11):791-4. PubMed ID: 14650104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between smoking and homocysteine concentration in ischemic stroke patients].
    Qiao SD; Liu N; Fan DS; Gao XH; Zhou JW
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(47):3342-4. PubMed ID: 19257965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
    Hassan A; Hunt BJ; O'Sullivan M; Bell R; D'Souza R; Jeffery S; Bamford JM; Markus HS
    Brain; 2004 Jan; 127(Pt 1):212-9. PubMed ID: 14607791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factors determining hyperhomocysteinemia in the chronic phase of strokes].
    Carod-Artal FJ; Nunes SV; Vargas AP; Portugal D
    Rev Neurol; 2007 May 1-15; 44(9):513-9. PubMed ID: 17492607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients.
    Tseng YL; Chang YY; Liu JS; Su CS; Lai SL; Lan MY
    J Neurol Sci; 2009 Sep; 284(1-2):36-9. PubMed ID: 19398115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese.
    Iso H; Moriyama Y; Sato S; Kitamura A; Tanigawa T; Yamagishi K; Imano H; Ohira T; Okamura T; Naito Y; Shimamoto T
    Circulation; 2004 Jun; 109(22):2766-72. PubMed ID: 15159287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids in ischemic stroke subtypes.
    Laloux P; Galanti L; Jamart J
    Acta Neurol Belg; 2004 Mar; 104(1):13-9. PubMed ID: 15143957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia: a risk factor for retinal vein occlusion.
    Yildirim C; Yaylali V; Tatlipinar S; Kaptanoğlu B; Akpinar S
    Ophthalmologica; 2004; 218(2):102-6. PubMed ID: 15004498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification.
    Pinto A; Tuttolomondo A; Di Raimondo D; Fernandez P; Licata G
    Int Angiol; 2006 Sep; 25(3):261-7. PubMed ID: 16878074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.